feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years
本文档由 coa062802 分享于2017-04-22 01:59
feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~